Mayo Clinic collaborates with Ultromics to rapidly assess patients diagnosed with COVID-19

Press releases may be edited for formatting or style | May 11, 2020 Artificial Intelligence

A joint UK-US research team is applying a pioneering artificial intelligence system to map for the first time how the COVID-19 virus attacks the heart with such deadly impact.

The coronavirus has been found to kill more than one in ten victims with heart disease and also to significantly weaken the hearts of other sufferers.

This week, British health-tech company Ultromics and Mayo Clinic in the US will use AI software, EchoGo Core, to analyze echocardiograms of COVID-19 victims, for clues about how the virus affects the human cardiovascular system.

Training and education based on your needs

Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money

Their findings will produce, for the first time, a map of the 'novel cardiac features' of COVID-19 and help physicians rapidly triage and treat high-risk patients, potentially saving countless lives.



You Must Be Logged In To Post A Comment Sign In If you've already created an account, use your email address and password to sign in using the form below. Login Problems: Click here if you are having login issues. Email address: Password: Forgot your password? Login Problems? View our Legal Notice and Privacy Notice Register Registration is Free and Easy. Enjoy the benefits of The World's Leading New & Used Medical Equipment Marketplace. Register Now!